Renal interstitial hyaluronan: Functional aspects during normal and pathological conditions

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 302, Issue 11, 2012, Pages

  Stridh, Sara ^a   Palm, Fredrik ^a,b   Hansell, Peter ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Cyclosporine A; Diabetes; Hydration status; Ischemia reperfusion; Kidney; Kidney stone; Nephropathy; Transplantation

Indexed keywords

ANGIOTENSIN II; CALCIUM ION; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GUANINE NUCLEOTIDE BINDING PROTEIN; HERMES ANTIGEN; HYALURONAN RECEPTOR FOR ENDOCYTOSIS; HYALURONAN SYNTHASE; HYALURONIC ACID; HYALURONIC ACID BINDING PROTEIN; HYALURONIDASE; INDOMETACIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LAYILIN; LYMPHATIC VESSEL ENDOTHELIAL RECEPTOR 1; MEMBRANE PROTEIN; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PHOSPHOLIPASE C; PROSTAGLANDIN; PROSTAGLANDIN E2; PROTEIN KINASE C; SYNTHETASE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASOPRESSIN; VASOPRESSIN V1 RECEPTOR; VASOPRESSIN V2 RECEPTOR;

CELL ADHESION; CELL AGGREGATION; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; CELLULAR DISTRIBUTION; DIURESIS; DRUG EFFICACY; DRUG SAFETY; ENDOCYTOSIS; EXTRACELLULAR MATRIX; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HYDRATION; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CORTEX; KIDNEY DEVELOPMENT; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY INTERSTITIUM; KIDNEY METABOLISM; KNOWLEDGE; LYMPH VESSEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; PROTEIN SECRETION; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD44; HOMEOSTASIS; HUMANS; HYALURONIC ACID; KIDNEY; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; REPERFUSION INJURY;

EID: 84861838948     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00332.2011     Document Type: Review

References (170)

1. Agre P. Nobel lecture. Aquaporin water channels. Biosci Rep 24: 127-163, 2004.
2. Alpern RJ, Herbert SC, Seldin DW, Giebisch GH. Seldin and Giebisch's The Kidney: Physiology and Pathophysiology. Amsterdam: London: Academic, 2008.
3. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T. Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25: 496-501, 1983.
4. Armstrong SE, Bell DR. Relationship between lymph and tissue hyaluronan in skin and skeletal muscle. Am J Physiol Heart Circ Physiol 283: H2485-H2494, 2002.
5. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 61: 1303-1313, 1990.
6. Asselman M. Hyaluronan Biology and Regulation In Renal Tubular Epithelial Cells and Its Role in Kidney Stone Disease. Rotterdam, The Netherlands: Erasmus University, 2008.
7. Asselman M, Verhulst A, De Broe ME, Verkoelen CF. Calcium oxalate crystal adherence to hyaluronan-, osteopontin-, CD44-expressing injured/regenerating tubular epithelial cells in rat kidneys. J Am Soc Nephrol 14: 3155-3166, 2003.
8. Asselman M, Verhulst A, Van Ballegooijen ES, Bangma CH, Verkoelen CF, De Broe ME. Hyaluronan is apically secreted and expressed by proliferating or regenerating renal tubular cells. Kidney Int 68: 71-83, 2005.
9. Baddouri K, Quyou A. [Osmolality and secretion of vasopressins during pregnancy in Meriones crassus]. Reprod Nutr Dev 31: 535-539, 1991.
10. Banerji S, Ni J, Wang SX, Clasper S, Su J, Tammi R, Jones M, Jackson DG. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 144: 789-801, 1999.
11. Belsky E, Toole BP. Hyaluronate and hyaluronidase in the developing chick embryo kidney. Cell Diff 12: 61-66, 1983.
12. Berenson GS, Ruiz H, Dalferes ER Jr, Dugan FA, Radhakrishnamurthy B. Acid mucopolysaccharide changes in diabetic kidneys. Diabetes 19: 161-170, 1970.
13. Bohman SO, Jensen PK. The interstitial cells in the renal medulla of rat, rabbit, gerbil in different states of diuresis. Cell Tissue Res 189: 1-18, 1978.
14. Bollet AJ, BonnerWMJr, Nance JL. The presence of hyaluronidase in various mammalian tissues. J Biol Chem 238: 3522-3527, 1963.
15. Bono P, Rubin K, Higgins JM, Hynes RO. Layilin, a novel integral membrane protein, is a hyaluronan receptor. Mol Biol Cell 12: 891-900, 2001.
16. Bonventre JV, Weinberg JM. Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 14: 2199-2210, 2003.
17. Borghi L, Meschi T, Schianchi T, Briganti A, Guerra A, Allegri F, Novarini A. Urine volume: stone risk factor and preventive measure. Nephron 81, Suppl 1: 31-37, 1999.
18. Bourguignon LY, Singleton PA, Diedrich F, Stern R, Gilad E. CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion. J Biol Chem 279: 26991-27007, 2004.
19. Camenisch TD, Spicer AP, Brehm-Gibson T, Biesterfeldt J, Augustine ML, Calabro A Jr, Kubalak S, Klewer SE, McDonald JA. Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J Clin Invest 106: 349-360, 2000.
20. Campo GM, Avenoso A, Micali A, Nastasi G, Squadrito F, Altavilla D, Bitto A, Polito F, Rinaldi MG, Calatroni A, D'Ascola A, Campo S. High-molecular weight hyaluronan reduced renal PKC activation in genetically diabetic mice. Biochim Biophys Acta 1802: 1118-1130, 2010.
21. Chen J, Zhao M, Rao R, Inoue H, Hao CM. C/EBPβ and its binding element are required for NFκB-induced COX2 expression following hypertonic stress. J Biol Chem 280: 16354-16359, 2005.
22. Comper WD, Laurent TC. Physiological function of connective tissue polysaccharides. Physiol Rev 58: 255-315, 1978.
23. Costerousse O, Allegrini J, Huang H, Bounhik J, Alhenc-Gelas F. Regulation of ACE gene expression and plasma levels during rat postnatal development. Am J Physiol Endocrinol Metab 267: E745-E753, 1994.
24. Csoka AB, Frost GI, Stern R. The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biol 20: 499-508, 2001.
25. Csoka AB, Scherer SW, Stern R. Expression analysis of six paralogous human hyaluronidase genes clustered on chromosomes 3p21 and 7q31. Genomics 60: 356-361, 1999.
26. Culty M, Nguyen HA, Underhill CB. The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J Biol Chem 116: 1055-1062, 1992.
27. Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Twenty-fourhour urine chemistries and the risk of kidney stones among women and men. Kidney Int 59: 2290-2298, 2001.
28. Darby IA, Sernia C. In situ hybridization and immunohistochemistry of renal angiotensinogen in neonatal and adult rat kidneys. Cell Tissue Res 281: 197-206, 1995.
29. de Mattos AM, Olyaei AJ, Bennett WM. Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future. Am J Kidney Dis 35: 333-346, 2000.
30. DeAngelis PL. Hyaluronan synthases: fascinating glycosyltransferases from vertebrates, bacterial pathogens, algal viruses. Cell Mol Life Sci 56: 670-682, 1999.
31. Decleves AE, Caron N, Nonclercq D, Legrand A, Toubeau G, Kramp R, Flamion B. Dynamics of hyaluronan, CD44, inflammatory cells in the rat kidney after ischemia/reperfusion injury. Int J Mol Med 18: 83-94, 2006.
32. Diabetes Control and Complications Trial Research Group. effect of intensive treatment of diabetes on the development, and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986, 1993.
33. Duterme C, Mertens-Strijthagen J, Tammi M, Flamion B. Two novel functions of hyaluronidase-2 (Hyal2) are formation of the glycocalyx and control of CD44-ERM interactions. J Biol Chem 284: 33495-33508, 2009.
34. Dwyer TM, Banks SA, Alonso-Galicia M, Cockrell K, Carroll JF, Bigler SA, Hall JE. Distribution of renal medullary hyaluronan in lean and obese rabbits. Kidney Int 58: 721-729, 2000.
35. Edwards BA. The activity of the hypothalamo-neurohypophysis during rehydration following water deprivation in the gerbil (Meriones unguiculatus) and the laboratory rat (Rattus norvegicus). Comp Biochem Physiol A Comp Physiol 77: 557-561, 1984.
36. Eriksson S, Fraser JR, Laurent TC, Pertoft H, Smedsrod B. Endothelial cells are a site of uptake and degradation of hyaluronic acid in the liver. Exp Cell Res 144: 223-228, 1983.
37. Erikstrup C, Pedersen LM, Heickendorff L, Ledet T, Rasmussen LM. Production of hyaluronan and chondroitin sulphate proteoglycans from human arterial smooth muscle-the effect of glucose, insulin, IGF-I or growth hormone. Eur J Endocrinol 145: 193-198, 2001.
38. Evan AP, Coe FL, Gillen D, Lingeman JE, Bledsoe S, Worcester EM. Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones. Anat Rec (Hoboken) 291: 325-334, 2008.
39. Evanko SP, Angello JC, Wight TN. Formation of hyaluronan-and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 19: 1004-1013, 1999.
40. Falk RJ, Scheinman JI, Mauer SM, Michael AF. Polyantigenic expansion of basement membrane constituents in diabetic nephropathy. Diabetes 32, Suppl 2: 34-39, 1983.
41. Fitzgerald KA, Bowie AG, Skeffington BS, O'Neill LA. Ras, protein kinase C zeta, I kappa B kinases 1 and 2 are downstream effectors of CD44 during the activation of NF-kappa B by hyaluronic acid fragments in T-24 carcinoma cells. J Immunol 164: 2053-2063, 2000.
42. Flessner MF. The role of extracellular matrix in transperitoneal transport of water and solutes. Perit Dial Int 21, Suppl 3: S24-S29, 2001.
43. Formby B, Stern R. Lactate-sensitive response elements in genes involved in hyaluronan catabolism. Biochem Biophys Res Commun 305: 203-208, 2003.
44. Fraser JR, Kimpton WG, Laurent TC, Cahill RN, Vakakis N. Uptake and degradation of hyaluronan in lymphatic tissue. Biochem J 256: 153-158, 1988.
45. Fraser JR, Laurent TC, Laurent UB. Hyaluronan: its nature, distribution, functions and turnover. J Intern Med 242: 27-33, 1997.
46. Friberg P, Sundelin B, Bohman SO, Bobik A, Nilsson H, Wickman A, Gustafsson H, Petersen J, Adams MA. Renin-angiotensin system in neonatal rats: induction of a renal abnormality in response to ACE inhibition or angiotensin II antagonism. Kidney Int 45: 485-492, 1994.
47. Frost GI, Csoka AB, Wong T, Stern R. Purification, cloning, expression of human plasma hyaluronidase. Biochem Biophys Res Commun 236: 10-15, 1997.
48. Gerdin B, Hallgren R. Dynamic role of hyaluronan (HYA) in connective tissue activation and inflammation. J Int Med 242: 49-55, 1997.
49. Ginetzinsky AG. Role of hyaluronidase in the re-absorption of water in renal tubules: the mechanism of action of the antidiuretic hormone. Nature 182: 1218-1219, 1958.
50. Gmachl M, Sagan S, Ketter S, Kreil G. The human sperm protein PH-20 has hyaluronidase activity. FEBS Lett 336: 545-548, 1993.
51. Goransson V, Hansell P, Moss S, Alcorn D, Johnsson C, Hallgren R, Maric C. Renomedullary interstitial cells in culture; the osmolality and oxygen tension influence the extracellular amounts of hyaluronan and cellular expression of CD44. Matrix Biol 20: 129-136, 2001.
52. Goransson V, Johnsson C, Jacobson A, Heldin P, Hallgren R, Hansell P. Renal hyaluronan accumulation and hyaluronan synthase expression after ischaemia-reperfusion injury in the rat. Nephrol Dial Transplant 19: 823-830, 2004.
53. Goransson V, Johnsson C, Nylander O, Hansell P. Renomedullary and intestinal hyaluronan content during body water excess: a study in rats and gerbils. J Physiol 542: 315-322, 2002.
54. Guron G, Nilsson A, Nitescu N, Nielsen S, Sundelin B, Frokiaer J, Friberg P. Mechanisms of impaired urinary concentrating ability in adult rats treated neonatally with enalapril. Acta Physiol Scand 165: 103-112, 1999.
55. Guyton AC, Hall JE. Textbook of Medical Physiology. Philadelphia, PA: Saunders, 1996.
56. Hagenfeld D, Schulz T, Ehling P, Budde T, Schumacher U, Prehm P. Depolarization of the membrane potential by hyaluronan. J Cell Biochem 111: 858-864, 2010.
57. Hallgren R, Gerdin B, Tengblad A, Tufveson G. Accumulation of hyaluronan (hyaluronic acid) in myocardial interstitial tissue parallels development of transplantation edema in heart allografts in rats. J Clin Invest 85: 668-673, 1990.
58. Hallgren R, Gerdin B, Tufveson G. Hyaluronic acid accumulation and redistribution in rejecting rat kidney graft. Relationship to the transplantation edema. J Exp Med 171: 2063-2076, 1990.
59. Han DH, Song HK, Lee SY, Song JH, Piao SG, Yoon HE, Ghee JY, Yoon HJ, Kim J, Yang CW. Upregulation of hyaluronan and its binding receptors in an experimental model of chronic cyclosporine nephropathy. Nephrology (Carlton) 15: 216-224, 2010.
60. Hansell P, Goransson V, Odlind C, Gerdin B, Hallgren R. Hyaluronan content in the kidney in different states of body hydration. Kidney Int 58: 2061-2068, 2000.
61. Hansell P, Maric C, Alcorn D, Goransson V, Johnsson C, Hallgren R. Renomedullary interstitial cells regulate hyaluronan turnover depending on growth media osmolality suggesting a role in renal water handling. Acta Physiol Scand 165: 115-116, 1999.
62. Hardwick C, Hoare K, Owens R, Hohn HP, Hook M, Moore D, Cripps V, Austen L, Nance DM, Turley EA. Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility. J Cell Biol 117: 1343-1350, 1992.
63. Hascall VC, Majors AK, De La Motte CA, Evanko SP, Wang A, Drazba JA, Strong SA, Wight TN. Intracellular hyaluronan: a new frontier for inflammation? Biochim Biophys Acta 1673: 3-12, 2004.
64. Hua Q, Knudson CB, Knudson W. Internalization of hyaluronan by chondrocytes occurs via receptor-mediated endocytosis. J Cell Sci 106: 365-375, 1993.
65. Huang W, Lee SL, Sjoquist M. Effects of neurohypophyseal antagonists in postnephrectomy natriuresis in male rats. Kidney Int 45: 692-699, 1994.
66. Ikegami-Kawai M, Suzuki A, Karita I, Takahashi T. Increased hyaluronidase activity in the kidney of streptozotocin-induced diabetic rats. J Biol Chem 134: 875-880, 2003.
67. Itano N, Sawai T, Yoshida M, Lenas P, Yamada Y, Imagawa M, Shinomura T, Hamaguchi M, Yoshida Y, Ohnuki Y, Miyauchi S, Spicer AP, McDonald JA, Kimata K. Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem 274: 25085-25092, 1999.
68. Ivanova LN, Kabilova NO. [The effect of vasopressin and its analogs on hyaluronan-synthase type 2 gene expression in Wistar and vasopressindeficient Brattleboro rat kidney]. Ross Fiziol Zh Im I M Sechenova 95: 694-705, 2009.
69. Johnsson C, Tufveson G, Wahlberg J, Hallgren R. Experimentallyinduced warm renal ischemia induces cortical accumulation of hyaluronan in the kidney. Kidney Int 50: 1224-1229, 1996.
70. Jones S, Jones S, Phillips AO. Regulation of renal proximal tubular epithelial cell hyaluronan generation: implications for diabetic nephropathy. Kidney Int 59: 1739-1749, 2001.
71. Jung FF, Bouyounes B, Barrio R, Tang SS, Diamant D, Ingelfinger JR. Angiotensin converting enzyme in renal ontogeny: hypothesis for multiple roles. Pediatr Nephrol 7: 834-840, 1993.
72. Kanwar YS, Carone FA, Kumar A, Wada J, Ota K, Wallner EI. Role of extracellular matrix, growth factors and proto-oncogenes in metanephric development. Kidney Int 52: 589-606, 1997.
73. Kim Y, Kleppel MM, Butkowski R, Mauer SM, Wieslander J, Michael AF. Differential expression of basement membrane collagen chains in diabetic nephropathy. Am J Pathol 138: 413-420, 1991.
74. Knepper MA, Saidel GM, Hascall VC, Dwyer T. Concentration of solutes in the renal inner medulla: interstitial hyaluronan as a mechanoosmotic transducer. Am J Physiol Renal Physiol 284: F433-F446, 2003.
75. Kultti A, Rilla K, Tiihonen R, Spicer AP, Tammi RH, Tammi MI. Hyaluronan synthesis induces microvillus-like cell surface protrusions. J Biol Chem 281: 15821-15828, 2006.
76. Lai-Fook SJ, Brown LV. Effects of electric charge on hydraulic conductivity of pulmonary interstitium. J Appl Physiol 70: 1928-1932, 1991.
77. Laurent TC, Fraser JR. Hyaluronan. FASEB J 6: 2397-2404, 1992.
78. Laurent TC, Lilja K, Brunnberg L, Engström-Laurent A, Laurent UB, Lindqvist U, Murata K, Ytterberg D. Urinary excretion of hyaluronan in man. Scand J Clin Lab Invest 47: 793-799, 1987.
79. Laurent UBG. On the origin of hyaluronate in blood. Biochem Int 2: 195-199, 1981.
80. Lee JY, Spicer AP. Hyaluronan: a multifunctional, megaDalton, stealth molecule. Curr Opin Cell Biol 12: 581-586, 2000.
81. Leon CA, Raij L. Interaction of haemodynamic and metabolic pathways in the genesis of diabetic nephropathy. J Hypertens 23: 1931-1937, 2005.
82. Lepperdinger G, Strobl B, Kreil G. HYAL2, a human gene expressed in many cells, encodes a lysosomal hyaluronidase with a novel type of specificity. J Biol Chem 273: 22466-22470, 1998.
83. Levick JR. Flow through interstitium and other fibrous matrices. Q J Exp Physiol 72: 409-437, 1987.
84. Lewington AJ, Padanilam BJ, Martin DR, Hammerman MR. Expression of CD44 in kidney after acute ischemic injury in rats. Am J Physiol Regul Integr Comp Physiol 278: R247-R254, 2000.
85. Lewis A, Steadman R, Manley P, Craig K, de la Motte C, Hascall V, Phillips AO. Diabetic nephropathy, inflammation, hyaluronan and interstitial fibrosis. Histol Histopathol 23: 731-739, 2008.
86. Mahadevan P, Larkins RG, Fraser JR, Fosang AJ, Dunlop ME. Increased hyaluronan production in the glomeruli from diabetic rats: a link between glucose-induced prostaglandin production and reduced sulphated proteoglycan. Diabetologia 38: 298-305, 1995.
87. Malathy K, Kurup PA. Metabolism of glycosaminoglycans in alloxan diabetic rats. I. Changes in tissue glycosaminoglycans. Diabetes 21: 1162-1167, 1972.
88. Markovitz A, Cifonelli JA, Dorfman A. The biosynthesis of hyaluronic acid by group A Streptococcus. VI. Biosynthesis from uridine nucleotides in cell-free extracts. J Biol Chem 234: 2343-2350, 1959.
89. Marre M, Hallab M, Roy J, Lejeune JJ, Jallet P, Fressinaud P. Glomerular hyperfiltration in type I, type II, secondary diabetes. J Diabetes Complications 6: 19-24, 1992.
90. McCourt PA, Ek B, Forsberg N, Gustafson S. Intercellular adhesion molecule-1 is a cell surface receptor for hyaluronan. J Biol Chem 269: 30081-30084, 1994.
91. McDonald JN, Levick JR. Effect of intra-articular hyaluronan on pressure-flow relation across synovium in anaesthetized rabbits. J Physiol 485: 179-193, 1995.
92. McKee CM, Lowenstein CJ, Horton MR, Wu J, Bao C, Chin BY, Choi AM, Noble PW. Hyaluronan fragments induce nitric-oxide synthase in murine macrophages through a nuclear factor kappaB-dependent mechanism. J Biol Chem 272: 8013-8018, 1997.
93. McKee CM, Penno MB, Cowman M, Burdick MD, Strieter RM, Bao C, Noble PW. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J Clin Invest 98: 2403-2413, 1996.
94. Melin J, Hellberg O, Funa K, Hallgren R, Larsson E, Fellstrom BC. Ischemia-induced renal expression of hyaluronan and CD44 in diabetic rats. Nephron Exp Nephrol 103: e86-94, 2006.
95. Moe OW. Kidney stones: pathophysiology and medical management. Lancet 367: 333-344, 2006.
96. Morse RM, Resnick MI. A new approach to the study of urinary macromolecules as a participant in calcium oxalate crystallization. J Urol 139: 869-873, 1988.
97. Moseley R, Waddington RJ, Embery G. Degradation of glycosaminoglycans by reactive oxygen species derived from stimulated polymorphonuclear leukocytes. Biochim Biophys Acta 1362: 221-231, 1997.
98. Najafian B, Mauer M. Progression of diabetic nephropathy in type 1 diabetic patients. Diabetes Res Clin Pract 83: 1-8, 2009.
99. Nardini M, Ori M, Vigetti D, Gornati R, Nardi I, Perris R. Regulated gene expression of hyaluronan synthases during Xenopus laevis development. Gene Expr Patterns 4: 303-308, 2004.
100. Nasrallah R, Landry A, Singh S, Sklepowicz M, Hebert RL. Increased expression of cyclooxygenase-1 and-2 in the diabetic rat renal medulla. Am J Physiol Renal Physiol 285: F1068-F1077, 2003.
101. Nath KA. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 20: 1-17, 1992.
102. Nielsen S, Chou CL, Marples D, Christensen EI, Kishore BK, Knepper MA. Vasopressin increases water permeability of kidney collecting duct by inducing translocation of aquaporin-CD water channels to plasma membrane. Proc Natl Acad Sci USA 92: 1013-1017, 1995.
103. Nilsson AB, Johnsson C, Friberg P, Hansell P. Renal cortical accumulation of hyaluronan in adult rats exposed neonatally to angiotensinconverting enzyme inhibition. Acta Physiolog Scand 173: 343-350, 2001.
104. Nishio S, Abe Y, Wakatsuki A, Iwata H, Ochi K, Takeuchi M, Matsumoto A. Matrix glycosaminoglycan in urinary stones. J Urol 134: 503-505, 1985.
105. Noble PW. Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol 21: 25-29, 2002.
106. Norwood VF, Craig MR, Harris JM, Gomez RA. Differential expression of angiotensin II receptors during early renal morphogenesis. Am J Physiol Regul Integr Comp Physiol 272: R662-R668, 1997.
107. Oghlakian G, Klapholz M. Vasopressin and vasopressin receptor antagonists in heart failure. Cardiol Rev 17: 10-15, 2009.
108. Oksala O, Salo T, Tammi R, Hakkinen L, Jalkanen M, Inki P, Larjava H. Expression of proteoglycans and hyaluronan during wound healing. J Histochem Cytochem 43: 125-135, 1995.
109. Parameswaran S, Brown LV, Lai-Fook SJ. Effect of flow on hydraulic conductivity and reflection coefficient of rabbit mesentery. Microcirculation 5: 265-274, 1998.
110. Pedagogos E, Hewitson TD, Nicholls KM, Becker GJ. Hyaluronan and rat renal fibroblasts: in vitro studies. Nephron 88: 347-353, 2001.
111. Pinheiro HS, Camara NO, Osaki KS, De Moura LA, Pacheco-Silva A. Early presence of calcium oxalate deposition in kidney graft biopsies is associated with poor long-term graft survival. Am J Transplant 5: 323-329, 2005.
112. Pitcock JA, Lyons H, Brown PS, Rightsel WA, Muirhead EE. Glycosaminoglycans of the rat renomedullary interstitium: ultrastructural and biochemical observations. Exp Mol Pathol 49: 373-387, 1988.
113. Platt JL, Trescony P, Lindman B, Oegema TR. Heparin and heparan sulfate delimit nephron formation in fetal metanephric kidneys. Dev Biol 139: 338-348, 1990.
114. Pohl M, Sakurai H, Stuart RO, Nigam SK. Role of hyaluronan and CD44 in in vitro branching morphogenesis of ureteric bud cells. Dev Biol 224: 312-325, 2000.
115. Pohl M, Stuart RO, Sakurai H, Nigam SK. Branching morphogenesis during kidney development. Annu Rev Physiol 62: 595-620, 2000.
116. Powell JD, Horton MR. Threat matrix: low-molecular-weight hyaluronan (HA) as a danger signal. Immunol Res 31: 207-218, 2005.
117. Prehm P. Synthesis of hyaluronate in differentiated teratocarcinoma cells. Mechanism of chain growth. Biochem J 211: 191-198, 1983.
118. Prevo R, Banerji S, Ferguson DJ, Clasper S, Jackson DG. Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. J Biol Chem 276: 19420-19430, 2001.
119. Pruitt ME, Knepper MA, Graves B, Schmidt-Nielsen B. Effect of peristaltic contractions of the renal pelvic wall on solute concentrations of the renal inner medulla in the hamster. Am J Physiol Renal Physiol 290: F892-F896, 2006.
120. Pummill PE, DeAngelis PL. Alteration of polysaccharide size distribution of a vertebrate hyaluronan synthase by mutation. J Biol Chem 278: 19808-19814, 2003.
121. Rockey DC, Chung JJ, McKee CM, Noble PW. Stimulation of inducible nitric oxide synthase in rat liver by hyaluronan fragments. Hepatology 27: 86-92, 1998.
122. Rosengren BI, Carlsson O, Rippe B. Hyaluronan and peritoneal ultrafiltration: a test of the "filter-cake" hypothesis. Am J Kidney Dis 37: 1277-1285, 2001.
123. Rugheimer L, Carlsson C, Johnsson C, Hansell P. Renal hyaluronan content during experimental uncontrolled diabetes in rats. J Physiol Pharmacol 59: 115-128, 2008.
124. Rugheimer L, Johnsson C, Hansell P. Nitric oxide and prostaglandins influence the renomedullary hyaluronan content. In: Hyaluronan-Structure, Metabolism, Biological Activities, Therapeutic Applications, edited by VC Hascall, EA Balazs. Edgewater, NJ: Matrix Biology Institute, 2005, p. 773-775.
125. Rugheimer L, Johnsson C, Maric C, Hansell P. Hormonal regulation of renomedullary hyaluronan. Acta Physiol (Oxf) 193: 191-198, 2008.
126. Rugheimer L, Olerud J, Johnsson C, Takahashi T, Shimizu K, Hansell P. Hyaluronan synthases and hyaluronidases in the kidney during changes in hydration status. Matrix Biol 28: 390-395, 2009.
127. Sabaratnam S, Arunan V, Coleman PJ, Mason RM, Levick JR. Size selectivity of hyaluronan molecular sieving by extracellular matrix in rabbit synovial joints. J Physiol 567: 569-581, 2005.
128. Schainuck LI, Striker GE, Cutler RE, Benditt EP. Structural-functional correlations in renal disease. II. The correlations. Hum Pathol 1: 631-641, 1970.
129. Schell-Feith EA, Kist-van Holthe JE, Conneman N, van Zwieten PH, Holscher HC, Zonderland HM, Brand R, van der Heijden BJ. Etiology of nephrocalcinosis in preterm neonates: association of nutritional intake and urinary parameters. Kidney Int 58: 2102-2110, 2000.
130. Schmidt-Nielsen B. August Krogh Lecture. The renal concentrating mechanism in insects and mammals: a new hypothesis involving hydrostatic pressures. Am J Physiol Regul Integr Comp Physiol 268: R1087-R1100, 1995.
131. Selbi W, de la Motte C, Hascall V, Phillips A. BMP-7 modulates hyaluronan-mediated proximal tubular cell-monocyte interaction. J Am Soc Nephrol 15: 1199-1211, 2004.
132. Serradeil L, Gal C., Raufaste D., Marty E., Garcia C., Maffrand JP, Le Fur G. Autoradiographic localization of vasopressin V1a receptors in the rat kidney using [3H]-SR 49059. Kidney Int 50: 499-505, 1996.
133. Shotan A, Widerhorn J, Hurst A, Elkayam U. Risks of angiotensinconverting enzyme inhibition during pregnancy: experimental and clinical evidence, potential mechanisms, recommendations for use. Am J Med 96: 451-456, 1994.
134. Spicer AP, Augustine ML, McDonald JA. Molecular cloning and characterization of a putative mouse hyaluronan synthase. J Biol Chem 271: 23400-23406, 1996.
135. Spicer AP, McDonald JA. Characterization and molecular evolution of a vertebrate hyaluronan synthase gene family. J Biol Chem 273: 1923-1932, 1998.
136. Spicer AP, Seldin MF, Olsen AS, Brown N, Wells DE, Doggett NA, Itano N, Kimata K, Inazawa J, McDonald JA. Chromosomal localization of the human and mouse hyaluronan synthase genes. Genomics 41: 493-497, 1997.
137. Spitzer A, Chevalier Robert L. The developing kidney and the process of growth. In: The Kidney: Physiology and Pathophysiology (2nd ed.), edited by Seldin DW and Giebisch GH. New York: Raven, 1992, p. 829-883.
138. Steffes MW, Bilous RW, Sutherland DE, Mauer SM. Cell and matrix components of the glomerular mesangium in type I diabetes. Diabetes 41: 679-684, 1992.
139. Stern R. Hyaluronan catabolism: a new metabolic pathway. Eur J Cell Biol 83: 317-325, 2004.
140. Stridh S, Kerjaschki D, Chen Y, Rugheimer L, Astrand AB, Johnsson C, Friberg P, Olerud J, Palm F, Takahashi T, Ikegami-Kawai M, Hansell P. Angiotensin converting enzyme inhibition blocks interstitial hyaluronan dissipation in the neonatal rat kidney via hyaluronan synthase 2 and hyaluronidase 1. Matrix Biol 30: 62-69, 2011.
141. Sulyok E, Nyul Z. Hyaluronan-related limited concentration by the immature kidney. Med Hypotheses 65: 1058-1061, 2005.
142. Takeda M, Babazono T, Nitta K, Iwamoto Y. High glucose stimulates hyaluronan production by renal interstitial fibroblasts through the protein kinase C and transforming growth factor-beta cascade. Metab Clin Exp 50: 789-794, 2001.
143. Tammi R, Rilla K, Pienimaki JP, MacCallum DK, Hogg M, Luukkonen M, Hascall VC, Tammi M. Hyaluronan enters keratinocytes by a novel endocytic route for catabolism. J Biol Chem 276: 35111-35122, 2001.
144. Thomas L, Byers HR, Vink J, Stamenkovic I. CD44H regulates tumor cell migration on hyaluronate-coated substrate. J Cell Biol 118: 971-977, 1992.
145. Tilney NL, Guttmann RD. Effects of initial ischemia/reperfusion injury on the transplanted kidney. Transplantation 64: 945-947, 1997.
146. Titze J, Machnik A. Sodium sensing in the interstitium and relationship to hypertension. Curr Opin Nephrol Hypertens 19: 385-392, 2010.
147. Tomida M, Koyama H, Ono T. Effects of adenosine 3=:5=-cyclic monophosphate and serum on synthesis of hyaluronic acid in confluent rat fibroblasts. Biochem J 162: 539-543, 1977.
148. Toole BP. Hyaluronan in morphogenesis. J Int Med 242: 35-40, 1997.
149. Tufro-McReddie A, Harrison JK, Everett AD, Gomez RA. Ontogeny of type 1 angiotensin II receptor gene expression in the rat. J Clin Invest 91: 530-537, 1993.
150. Turley EA. Hyaluronan and cell locomotion. Cancer Metast Rev 11: 21-30, 1992.
151. Verhulst A, Asselman M, De Naeyer S, Vervaet BA, Mengel M, Gwinner W, D'Haese PC, Verkoelen CF, De Broe ME. Preconditioning of the distal tubular epithelium of the human kidney precedes nephrocalcinosis. Kidney Int 68: 1643-1647, 2005.
152. Verkoelen CF. Crystal retention in renal stone disease: a crucial role for the glycosaminoglycan hyaluronan? J Am Soc Nephrol 17: 1673-1687, 2006.
153. Verkoelen CF. The role of hyaluronan in renal stone disease. Glycoforum, 2007.
154. Wang A, de la Motte C, Lauer M, Hascall V. Hyaluronan matrices in pathobiological processes. FEBS J 278: 1412-1418, 2011.
155. Wang A, Hascall VC. Hyaluronan structures synthesized by rat mesangial cells in response to hyperglycemia induce monocyte adhesion. J Biol Chem 279: 10279-10285, 2004.
156. Wang T, Cheng HH, Heimbürger O, Chen C, Waniewski J, Bergström J, Lindholm B. Hyaluronan decreases peritoneal fluid absorption: effect of molecular weight and concentration of hyaluronan. Kidney Int 55: 667-673, 1999.
157. Weigel JA, Raymond RC, Weigel PH. The hyaluronan receptor for endocytosis (HARE) is not CD44 or CD54 (ICAM-1). Biochem Biophys Res Commun 294: 918-922, 2002.
158. Weigel PH, Hascall VC, Tammi M. Hyaluronan synthases. J Biol Chem 272: 13997-14000, 1997.
159. Wells A, Larsson E, Hanas E, Laurent T, Hallgren R, Tufveson G. Increased hyaluronan in acutely rejecting human kidney grafts. Transplantation 55: 1346-1349, 1993.
160. Wells AF, Larsson E, Tengblad A, Fellstrom B, Tufveson G, Klareskog L, Laurent TC. The localization of hyaluronan in normal and rejected human kidneys. Transplantation 50: 240-243, 1990.
161. Wiig H, Gyenge C, Iversen PO, Gullberg D, Tenstad O. The role of the extracellular matrix in tissue distribution of macromolecules in normal and pathological tissues: potential therapeutic consequences. Microcirculation 15: 283-296, 2008.
162. Yang T, Zhang A, Pasumarthy A, Zhang L, Warnock Z, Schnermann JB. Nitric oxide stimulates COX-2 expression in cultured collecting duct cells through MAP kinases and superoxide but not cGMP. Am J Physiol Renal Physiol 291: F891-F895, 2006.
163. Yannariello-Brown J, Frost SJ, Weigel PH. Identification of the Ca(2+)-independent endocytic hyaluronan receptor in rat liver sinusoidal endothelial cells using a photoaffinity cross-linking reagent. J Biol Chem 267: 20451-20456, 1992.
164. Yip JW, Jones SL, Wiseman MJ, Hill C, Viberti G. Glomerular hyperfiltration in the prediction of nephropathy in IDDM: a 10-year follow-up study. Diabetes 45: 1729-1733, 1996.
165. Young BA, Johnson RJ, Alpers CE, Eng E, Gordon K, Floege J, Couser WG, Seidel K. Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int 47: 935-944, 1995.
166. Zakaria ER, Lofthouse J, Flessner MF. In vivo effects of hydrostatic pressure on interstitium of abdominal wall muscle. Am J Physiol Heart Circ Physiol 276: H517-H529, 1999.
167. Zawieja DC, Garcia C, Granger HJ. Oxygen radicals, enzymes, and fluid transport through pericardial interstitium. Am J Physiol Heart Circ Physiol 262: H136-H143, 1992.
168. Zhou B, Weigel JA, Fauss L, Weigel PH. Identification of the hyaluronan receptor for endocytosis (HARE). J Biol Chem 275: 37733-37741, 2000.
169. Zhuo J, Dean R, Maric C, Aldred PG, Harris P, Alcorn D, Mendelsohn FA. Localization and interactions of vasoactive peptide receptors in renomedullary interstitial cells of the kidney. Kidney Int Suppl 67: S22-S28, 1998.
170. Zhuo JL. Renomedullary interstitial cells: a target for endocrine and paracrine actions of vasoactive peptides in the renal medulla. Clin Exp Pharmacol Physiol 27: 465-473, 2000.